Estrigenix Therapeutics
PrivateLast Round
Seed
Jul 21, 2026
Total Funding Raised
$474,056
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Estrigenix Therapeutics is a biotechnology company developing innovative therapies for menopausal symptoms, including hot flashes and memory dysfunction, by targeting selective estrogen receptor beta.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Estrigenix Therapeutics Comparables
Compare Estrigenix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MenoGeniX, Inc. | 86% | |
| Tioga Pharmaceuticals | 86% | |
| Astellas Pharma Inc. | 77% | |
Estrigenix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 21, 2026 | ||||
| Grant | Jun 19, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 1, 2022 | ||||
| SAFE | Jun 1, 2022 |
Key People
Founding team and executive leadership
Estrigenix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wisconsin Economic Development Corporation | Grant |
| UWM Research Foundation | Grant |
| Concordia Angel Network | SAFE |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 21, 2026
$2M round led by Talents Fund I
- May 14, 2026
Monthly visitors grew 610% MoM, from 20 to 142.
Estrigenix Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Estrigenix Therapeutics's valuation, stock price, and market status.